Join the Pain group to help and get support from people like you.
Pain News (Page 3)
Reiki May Help Ease the Pain of Cancer Treatment
FRIDAY, Dec. 13, 2024 – The ancient Japanese practice of reiki "energy healing" might help some cancer patients deal with the pain that can come with infusion therapies, new research shows....
24.3 Percent of U.S. Adults Had Chronic Pain in Past Three Months in 2023
THURSDAY, Nov. 21, 2024 – In 2023, 24.3 percent of U.S. adults had chronic pain in the previous three months, according to a November data brief published by the National Center for Health...
Spinal Cord Stimulation Holds Promise for Chronic Pain
WEDNESDAY, Nov. 20, 2024 – Spinal cord stimulation (SCS) for treatment of chronic pain in the back and/or lower extremities is associated with greater improvements in pain compared with conventional...
Certain Painkillers Can Raise Bleeding Risks for People on Blood Thinners
MONDAY, Nov. 18, 2024 – People on blood thinners have a doubled risk of dangerous internal bleeding if they also take a non-steroidal anti-inflammatory drug (NSAID) like ibuprofen or naproxen, a new...
Micronized Amnion/Chorion Aids Interstitial Cystitis/Bladder Pain Syndrome
THURSDAY, Oct. 31, 2024 – Injected micronized amnion/chorion bilayer (AC) product significantly reduces time to symptom relief in patients with refractory interstitial cystitis/bladder pain syndrome...
Protega Pharmaceuticals Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
PRINCETON, N.J., Oct. 29, 2024 /PRNewswire/ – Protega Pharmaceuticals Inc., an innovative specialty pharmaceutical company focused on responsible pain management and the development of novel...
American Society of Anesthesiologists, Oct. 18 to 22
The annual meeting of the American Society of Anesthesiologists was held from Oct. 18 to 22 in Philadelphia, attracting approximately 5,000 participants from around the world, including a...
Will Injury Pain Become Chronic? Brain Scans Might Tell
FRIDAY, Oct. 25, 2024 – Brain scans can provide early warning of who will develop chronic pain following a whiplash injury, a new study finds. Higher levels of “cross talk” between two specific bra...
Methadone Tied to Lower Risk for Discontinuation Versus Buprenorphine/Naloxone
FRIDAY, Oct. 18, 2024 – Receipt of methadone for opioid use disorder is associated with a lower risk for treatment discontinuation compared with buprenorphine/naloxone, according to a study...
Patients With Rheumatoid Arthritis Frequently Have Persisting Pain
THURSDAY, Oct. 10, 2024 – Patients with rheumatoid arthritis (RA) undergoing standard-of-care treatment frequently have persisting pain, according to a study published online Sept. 30 in the Annals...
Trauma at Life's Beginning Can Mar Its End, Study Finds
FRIDAY, Oct. 4, 2024 – Whether abusive parents, drug addiction or gun violence are to blame, the fallout from childhood traumas can reverberate until a person's final days of life, new research...
Guideline Developed for Opioid Prescribing in Children With Acute Pain
MONDAY, Sept. 30, 2024 – In a clinical practice guideline issued by the American Academy of Pediatrics and published online Sept. 30 in Pediatrics, recommendations are presented for opioid...
UBE Microdiscectomy Beneficial for Lumbar Disc Herniation
TUESDAY, Sept. 24, 2024 – For adults with symptomatic lumbar disc herniation, unilateral biportal endoscopic (UBE) microdiscectomy is associated with longer operating times and with lower pain...
FDA Medwatch Alert: FDA Warns Consumers to Avoid Certain Topical Pain Relief Products Due to Potential for Dangerous Health Effects
March 26, 2024 – The U.S. Food and Drug Administration is warning consumers not to use certain over-the-counter analgesic (pain relief) products that are marketed for topical use to relieve pain...
Vertex Announces Statistically Significant and Clinically Meaningful Results From Two Phase 2 Proof-of-Concept Studies of VX-548 for the Treatment of Acute Pain
Treatment with the NaV1.8 inhibitor VX-548 met the primary endpoint in both Phase 2 proof-of-concept acute pain studies following abdominoplasty or bunionectomy surgery VX-548 was generally well...
Further information
Related condition support groups
Chronic Pain, Back Pain, Fibromyalgia, Headache, Muscle Pain, Neuralgia, Neck Pain, Chronic Myofascial Pain, Reflex Sympathetic Dystrophy Syndrome, Nocturnal Leg Cramps, Breakthrough Pain
Related drug support groups
gabapentin, tramadol, oxycodone, ibuprofen, Tylenol, hydrocodone, naproxen, acetaminophen, meloxicam, view more... amitriptyline, aspirin, Percocet, hydroxyzine, Norco, duloxetine, pregabalin, diclofenac, methadone, codeine, cyclobenzaprine, OxyContin, Vicodin, Celebrex, Aleve, fentanyl, Advil, Voltaren, morphine, clonidine, buprenorphine, Paracetamol Teva, nortriptyline, Paracetamol, Butrans, cannabis, Motrin, Tylenol PM, Dilaudid, indomethacin, Toradol, Ultram, Lortab, Vistaril, acetaminophen / hydrocodone, ketamine, Roxicodone, Arthritis Pain, ketorolac, Atarax, Percocet 10/325, hydromorphone, Nucynta, Belbuca